# FDA Inspection 1207331 - David Boyer, MD - May 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/david-boyer-md/299466c8-286d-48a5-ae29-8e0550da11c5
Source feed: FDA_Inspections

> FDA Inspection 1207331 for David Boyer, MD on May 26, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207331
- Company Name: David Boyer, MD
- Inspection Date: 2023-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 775647 - 2012-04-04](https://www.keypedia.com/records/fda_inspections/david-boyer-md/62b47000-bcc4-42f4-872f-8536914350f3)

Company: https://www.keypedia.com/companies/david-boyer-md/499a3ac5-1014-4732-bfda-b67f7dfbfdef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c